Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Nov 08, 2024
Over the past two decades, the majority of countries in the 7MM have experienced a decrease in cervical cancer cases. In the United States, incidence rates declined from the mid-1970s to the mid-2000s, partly attributed to increased screening efforts. Cervical cancer is most often diagnosed between the age...
Read More...
Nov 08, 2024
Cervical cancer stands as the fourth most diagnosed cancer among women globally, trailing breast, colorectal, and lung cancers. However, its impact is disproportionately heavy on developing nations, where prevalence rates soar. In 2022, WHO estimated approximately 660,000 new cases of cervical cancer and 350,000 de...
Read More...
Nov 07, 2024
Cervical cancer is the fourth most common type of cancer and the fourth leading cause of death in women. According to the WHO, HPV infections contribute to an estimated 530,000 cases of cervical cancer and 264,000 related deaths annually, with over 85% of these fatalities occurring in low- and middle-income countri...
Read More...
Jan 25, 2017
Cervical cancer remains one of the leading causes of cancer-related deaths worldwide. A recent publication in nature reported the extensive molecular characterization of 228 primary cervical cancers, and has been dubbed as the largest comprehensive genomic study of cervical cancer to date. The authors observed strik...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper